Key Documents
David Katzenstein
Academic Appointments
- Professor (Research), Medicine - Infectious Diseases
- Member, Bio-X
Contact Information
-
Academic Offices
Personal Information Email Tel (650) 725-6066 Tel (650) 725-8304
Professional Snapshot
Honors and Awards
- Distinguished Clinical Scientist Award, Doris Duke Charitable Trust (2000-2005)
Postdoctoral Advisees
Web Site Links
Scientific Focus
Research Interests
Treatment and evaluation of HIV infection
Clinical Trials
Publications
- Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis. J Acquir Immune Defic Syndr. 2009; (1): 106-13
- Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy. J Acquir Immune Defic Syndr. 2009; (1): 9-18
- Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe. Clin Infect Dis. 2009; (11): 1601-8
- CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. J Virol. 2009; (11): 5592-605
- Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance. Int J STD AIDS. 2008; (11): 780-1
Help